Rahi Systems Launches Cloud Strategy Headed by New CTO Matt Robinson
8.1.2020 19:00:00 EET | Business Wire | Press release
Rahi Systems announced today the launch of its cloud strategy and the addition of Matt Robinson as CTO for cloud and infrastructure. Robinson will lead the development of Rahi’s cloud services, which will leverage Rahi’s proven ability to deliver cost-effective and efficient data center infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005141/en/
Cloud practices, professional services, and managed services will complement Rahi’s industry-leading expertise in data center infrastructure. (Graphic: Business Wire)
Today, every enterprise uses cloud services but few rely on the cloud exclusively. Many organizations need help developing a holistic approach across cloud and on-premises environments. The Rahi team can serve as that overlay, helping to align an organization’s cloud strategy with its data center strategy and implement the right mix of cloud services to meet business and IT requirements. Rahi also offers cloud managed services that fill skills gaps, ensure operational efficiency and optimize the cloud environment.
“Few IT solution providers offer cloud services, and most cloud companies must partner with VARs for on-premises solutions. Rahi can do both well,” said Tarun Raisoni, CEO & Co-Founder, Rahi Systems. “We are very excited to put a framework and methodology around our cloud strategy, and to have an industry veteran of Matt’s caliber heading up our cloud services.”
Robinson has been in the technology industry for the past 27 years, most recently as head of partner engineering at Google Cloud. He has previously held leadership roles at NetApp, Silicon Graphics and Alacritech across a variety of functions, including engineering, marketing, product management, professional services and customer support. “I’m delighted to be joining the Rahi family to help build a world-class cloud and infrastructure organization,” said Robinson. “Rahi’s longstanding data center and infrastructure experience at Fortune 500 clients helps set the stage for us to deliver hybrid and multi-cloud solutions across every industry vertical. With a strong focus on building a data strategy through strategic workload placement and strong governance models in cloud environments, Rahi will help its customers achieve their business goals faster and with more confidence.”
Learn more about Rahi’s cloud approach, methodology and service offerings by visiting Rahi Cloud Services.
About Rahi Systems
Rahi Systems delivers a suite of solutions and services that optimizes cost, performance, scalability, manageability and efficiency of today’s integrated environments. Founded in 2012 by entrepreneurs with deep understanding of the needs and challenges of service providers, government agencies and enterprises, the company has grown through a solutions-oriented approach, outstanding support and a culture of customer success. Rahi has its corporate headquarters in Fremont, Calif., with offices in the U.S., India, Hong Kong, Singapore, China, Taiwan, Turkey, Ireland, France, Germany, the Netherlands, the United Kingdom, Japan, South Korea, Malaysia, the Philippines, Indonesia, and Australia.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005141/en/
Contact information
Alison Lolis
VP of Marketing
+1 510.651.2205
alison@rahisystems.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila
PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom